Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 15

1958P - Head and neck soft tissue sarcoma: Evaluation of the 8th AJCC as a prognostic tool for patients treated with curative intent in a multidisciplinary cancer center

Date

21 Oct 2023

Session

Poster session 15

Topics

Staging Procedures;  Statistics

Tumour Site

Soft Tissue Sarcomas

Presenters

Giulia Zanetta

Citation

Annals of Oncology (2023) 34 (suppl_2): S1032-S1061. 10.1016/S0923-7534(23)01925-7

Authors

G.K. Zanetta

Author affiliations

  • Clinical Oncology, AC Camargo Cancer Center - Centro Internacional de Pesquisa (CIPE), 01508-010 - Sao Paulo/BR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1958P

Background

HN-STS is a challenging disease due to its diverse clinical presentation. In an attempt to refine the prognostication of these pts, the AJCC in its 8th edition proposed a new dedicated T staging group based on cutoffs of 2 and 4 cm for classifying T1, T2 and T3, and surrounding tissue invasion as T4, as opposed to the dichotomic T1-T2 5cm cutoff adopted by the 7th AJCC.

Methods

This is a retrospective study of pts diagnosed with nonmetastatic HN-STS treated with curative intent in a single tertiary hospital, approved by the institutional ethical review committee. The aim was to compare the 8th AJCC T staging to the previous classification as a prognostic tool for HN-STS, added to other variables such as age, histological subtype, grade and regional lymph node metastasis (LNM). AJCC 7th and 8th have been compared regarding T staging with Cohen’s kappa coefficient (KC) using inter-rater agreement analysis. The Kaplan-Meier estimator was used to calculate median survival time and differences in time-to-event outcomes were assessed using the log-rank test. Cox proportional hazard model was used to assess the effect of features in overall survival (OS).

Results

From 1997 to 2000, 135 pts were identified in institutional archives. Sarcoma NOS (N=50) and Leiomyosarcoma (N=17) were the most common histologic subtypes, as well as high-grade tumors (N=85). KC of inter-rater agreement was 0.46, statistically significant (p=0.03), indicating poor agreement between both T staging systems. Regarding OS, AJCC 7th (T1 and T2) and 8th (T1, T2, T3 and T4) T size stratification was not statistically different (P=0.42 and P=0.27, respectively). High-grade (71.4% vs 93.6%, P=0.005) and regional LNM (31.3% vs 81.4%, P=0.008) had worse 5-year OS in Cox multivariate analysis. Pts with tumor size>4cm or local invasion, high grade and LNM had 2.30, 7.11 and 4.37-fold increased risk of death respectively.

Conclusions

In our series, neither 7th nor 8th AJCC T size classifications adequately stratified prognostic groups or correlated survival for HN-STS pts. The 8th AJCC T4, the high-grade tumors and regional LNM demonstrated significant worse prognostic impact in pts harboring HN-STS.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The author.

Funding

Has not received any funding.

Disclosure

The author has declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.